KLP Kapitalforvaltning’s Ginkgo Bioworks DNA Stock Holding History

KLP Kapitalforvaltning’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$71.2K	Hold	7,183	–	–	﹤0.01%	2115
2026 Q1	$44K	Hold	7,183	–	–	﹤0.01%	2142
2025 Q4	$59.7K	Buy	7,183 +2,500	+53%	+$26.9K	﹤0.01%	2139
2025 Q3	$68.3K	Hold	4,683	–	–	﹤0.01%	2122
2025 Q2	$52.7K	Hold	4,683	–	–	﹤0.01%	2156
2025 Q1	$26.7K	Hold	4,683	–	–	﹤0.01%	2239
2024 Q4	$46K	Buy	+4,683	New	+$40.1K	﹤0.01%	2251

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

KLP Kapitalforvaltning's DNA Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 7,183 shares worth $71.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

KLP Kapitalforvaltning first reported a position in DNA in Q4 2024 and has held it in 7 quarters since. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

KLP Kapitalforvaltning held 7,183 shares of Ginkgo Bioworks worth $71.2K as of Q2 2026.
KLP Kapitalforvaltning left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2115 holding.
KLP Kapitalforvaltning first reported a position in Ginkgo Bioworks in Q4 2024 and has held it in 7 quarters since.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.